Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.
Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.